Zhang Jingbo, Tehrani Yousef Mazaheri, Wang Liang, Ishill Nicole M, Schwartz Larry H, Hricak Hedvig
Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, RM C278D, New York, NY 10021, USA.
Radiology. 2008 May;247(2):458-64. doi: 10.1148/radiol.2472070823.
To retrospectively assess the usefulness of apparent diffusion coefficients (ADCs) for characterizing renal masses (ie, viable solid tumors, necrotic or cystic tumor areas, and benign cysts).
The institutional review board waived the requirement for informed consent for this retrospective HIPAA-compliant study. The data of 25 consecutive patients (15 men, 10 women; age range, 39-75 years) who underwent renal magnetic resonance (MR) imaging, including diffusion-weighted imaging, before nephrectomy were included. Renal MR examinations were performed by using transverse T1-weighted dual-echo in-phase and out-of-phase sequences and transverse and coronal T2-weighted single-shot fast spin-echo sequences. Three-dimensional fat-saturated T1-weighted dynamic gadopentetate dimeglumine-enhanced sequences also were performed. Precontrast single-shot spin-echo echo-planar diffusion-weighted images were obtained with b values of 0, 500, and 1000 sec/mm(2) at 1.5 T. Regions of interest were placed on renal lesions to measure the ADC of whole lesions, enhancing viable soft tissue, and nonenhancing necrotic or cystic areas. The T1 signal characteristics of the renal lesions and necrotic or cystic areas were recorded. The Wilcoxon rank sum test was used to compare the median ADC values of the various types of lesions and areas.
Twenty-six renal tumors were found in the 25 patients. Eight patients were found to have 11 benign cysts. Renal tumors had significantly lower ADCs (median, 189.3 x 10(-5) mm(2)/sec; range, [102.0-262.0] x 10(-5) mm(2)/sec) compared with benign cysts (median, 322.8 x 10(-5) mm(2)/sec; range, [217.0-421.0] x 10(-5) mm(2)/sec; P < .001). Solid enhancing tumors had significantly lower ADCs (median, 162.3 x 10(-5) mm(2)/sec; range, [102.0-284.0] x 10(-5) mm(2)/sec) compared with nonenhancing necrotic or cystic regions (median, 247.7 x 10(-5) mm(2)/sec; range, [85.2-310.0] x 10(-5) mm(2)/sec; P = .007) [corrected]. T1 hyperintense lesions had lower ADCs compared with their hypointense counterparts.
The T1 signal characteristics of a renal lesion appear to be related to the ADC of the lesion. ADC may be helpful in characterizing and differentiating renal masses.
回顾性评估表观扩散系数(ADC)在肾肿块(即可存活实性肿瘤、坏死或囊性肿瘤区域以及良性囊肿)特征描述中的作用。
本符合健康保险流通与责任法案(HIPAA)的回顾性研究,经机构审查委员会批准无需患者知情同意。纳入25例连续患者(15例男性,10例女性;年龄范围39 - 75岁)的数据,这些患者在肾切除术前均接受了包括扩散加权成像在内的肾脏磁共振(MR)成像检查。肾脏MR检查采用横轴位T1加权双回波同相位和反相位序列以及横轴位和冠状位T2加权单次激发快速自旋回波序列。还进行了三维脂肪饱和T1加权动态钆喷酸葡胺增强序列检查。在1.5T场强下,获取b值为0、500和1000sec/mm²的预对比单次激发自旋回波平面扩散加权图像。在肾脏病变处放置感兴趣区,以测量整个病变、强化的可存活软组织以及未强化的坏死或囊性区域的ADC。记录肾脏病变及坏死或囊性区域的T1信号特征。采用Wilcoxon秩和检验比较不同类型病变及区域的ADC中位数。
25例患者共发现26个肾脏肿瘤。8例患者发现11个良性囊肿。与良性囊肿(中位数为322.8×10⁻⁵mm²/sec;范围为[217.0 - 421.0]×10⁻⁵mm²/sec;P <.001)相比,肾脏肿瘤的ADC明显更低(中位数为189.3×10⁻⁵mm²/sec;范围为[102.0 - 262.0]×10⁻⁵mm²/sec)。与未强化的坏死或囊性区域(中位数为247.7×10⁻⁵mm²/sec;范围为[85.2 - 310.0]×10⁻⁵mm²/sec;P =.007 [校正后])相比,实性强化肿瘤的ADC明显更低(中位数为162.3×10⁻⁵mm²/sec;范围为[102.0 - 284.0]×10⁻⁵mm²/sec)。T1高信号病变的ADC低于低信号病变。
肾脏病变的T1信号特征似乎与病变的ADC相关。ADC可能有助于肾肿块的特征描述和鉴别诊断。